Krystal Biotech buy Jefferies Financial Group Inc.
Start price
05.03.25
/
50%
€166.55
Target price
05.03.26
€228.54
Performance (%)
34.31%
End price
06.03.26
€223.70
Summary
This prediction ended on 06.03.26 with a price of €223.70. The BUY prediction by Jefferies_Financial_ for Krystal Biotech saw massive gains of 34.31%. Jefferies_Financial_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 16.614% | 16.614% | 112.434% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $245.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten